about
Micro-RNAs as Potential Predictors of Response to Breast Cancer Systemic Therapy: Future Clinical Implications.Transcript profiling distinguishes complete treatment responders with locally advanced cervical cancerAnti-inflammatory and Antitumor Activity of a Triple Therapy for a Colitis-Related Colorectal Cancer.Targeting Metabolic Remodeling in Triple Negative Breast Cancer in a Murine Model.MicroRNAs in cervical cancer: evidences for a miRNA profile deregulated by HPV and its impact on radio-resistance.Biochemical and proteomic analysis of spliceosome factors interacting with intron-1 of human papillomavirus type-16.MicroRNAs are involved in cervical cancer development, progression, clinical outcome and improvement treatment response (Review).MiR-26a downregulates retinoblastoma in colorectal cancer.PAX8 is transcribed aberrantly in cervical tumors and derived cell lines due to complex gene rearrangements.A few nucleotide polymorphisms are sufficient to recruit nuclear factors differentially to the intron 1 of HPV-16 intratypic variants.The HPV-16 E7 oncoprotein is expressed mainly from the unspliced E6/E7 transcript in cervical carcinoma C33-A cells.Alternative splicing regulation in tumor necrosis factor-mediated inflammation.Long Non-Coding RNAs as New Master Regulators of Resistance to Systemic Treatments in Breast CancerBRCA mutations: is everything said?Cell migration and proliferation are regulated by miR-26a in colorectal cancer via the PTEN-AKT axisA Multi-Center Study of BRCA1 and BRCA2 Germline Mutations in Mexican-Mestizo Breast Cancer Families Reveals Mutations Unreported in Latin American Population
P50
Q33838622-A9C2F355-C669-4C68-B891-8B96D743B2A4Q35555404-C7AEFF8E-0EE4-4C40-B60E-38FDF044EA81Q37290538-308C8C31-70D3-4632-A4C5-10D83020D3B9Q37667761-48311DED-BE64-4395-85DD-E9E7C84CDB6FQ38212798-553771BC-D671-4D35-9F3E-793C6B132D14Q38305124-15A04409-990B-4242-96D9-352B78E78EC9Q38623799-BFE0C315-61E4-457B-B1CA-342C501F634DQ38706042-D7D6862B-9F61-4F35-8C28-D4B6DC57C3E2Q38771332-D6ED1860-7BE6-448D-9F03-CFFAE62C96ACQ39378353-59620B7E-8207-4D4D-85AD-A84E216EAF76Q39652069-66C11C06-C738-4599-8DC6-553E2754AE1FQ47162174-D58BC11E-CD8A-4146-8BAA-039D05D4A10AQ57106074-69C5E067-F3BB-40CD-8CA6-9C7DA9354888Q57183250-F975B616-2E78-434E-9378-0223DBAFD474Q64083820-627BE692-6642-4BD9-BF86-520183AD28A3Q92905492-68A595B7-F82F-4FCB-A95C-9CEBAC0EEE5E
P50
description
researcher ORCID ID = 0000-0002-5307-2003
@en
wetenschapper
@nl
name
Eduardo López-Urrutia
@ast
Eduardo López-Urrutia
@en
Eduardo López-Urrutia
@es
Eduardo López-Urrutia
@nl
type
label
Eduardo López-Urrutia
@ast
Eduardo López-Urrutia
@en
Eduardo López-Urrutia
@es
Eduardo López-Urrutia
@nl
prefLabel
Eduardo López-Urrutia
@ast
Eduardo López-Urrutia
@en
Eduardo López-Urrutia
@es
Eduardo López-Urrutia
@nl
P106
P1153
57201259523
P21
P31
P496
0000-0002-5307-2003